FDA approves Regeneron's Libtayo for adults with high-risk cutaneous squamous cell carcinoma after surgery and radiation, ...
Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to ...
Regeneron gests US FDA approval for Libtayo as an adjuvant treatment of CSCC with a high risk of recurrence after surgery and radiation: Tarrytown, New York Friday, October 10, 20 ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.
President Donald Trump could soon move to cancel more than $1 billion in federal grants for General Motors Co. and Stellantis ...
A mid-West coffee giant known for brewing 20,000 unique beverages might be settling into Harrison. Founded in Arkansas and ...
As 240-foot-high power lines are set to rise across Sugarloaf, Pennsylvania, longtime residents are fighting eminent domain ...
The car wash proprietor who owns the land has sought to rezone and develop it before. Proposals to build next to the nature ...
Indiana’s business climate has been an advantage for a decade or more — consistently landing the state enviably high in ...
Safe Path Indy Housing, founded by Lionel Henderson earlier this year, is creating a transformative path forward for individuals transitioning out of incarceration. By providing rapid rehousing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback